Theranica

By Leontina Postelnicu 08:20 am August 23, 2019
Israel-headquartered MDClone, maker of a Synthetic Data Engine for healthcare, has raised $26m (€23.5m) in a Series B funding round led by aMoon, a VC fund focused on health tech and life sciences, it was announced this week. Existing backers OrbiMed Israel Partners and Lightspeed Venture Partners also participated in the raise. WHAT THEY DO According to MDClone, its engine examines original...
By MobiHealthNews 03:19 pm July 19, 2019
This quarter was another busy one for the FDA as it continued to reevaluate its approach to digital health amidst a changing of the guard from Dr. Scott Gottlieb to its new commissioner, Dr. Norman "Ned" Sharpless.  Among its most notable digital health actions of the past few months was the agency’s decision to put out a call for new companies to try out the current framework of its Digital...

Above photo: Tomoko Inoue, CEO of OMRON Ventures. Credit: OMRON Ventures

By Dean Koh 01:45 am July 16, 2019
With a background in biomedical science and rich experience in medical device venture capital investment, Tomoko Inoue possesses the technical, operational and business knowledge of what makes medtech startups successful – a role perfectly suited for her current role as the CEO of OMRON Ventures.  She believes that in a hyper aging society like Japan, there is a big need for smart infrastructure...

Above: Alon Ironi, CEO & Co-Founder, Theranica. Credit: Theranica

By Dean Koh 11:14 pm June 16, 2019
Pain is usually an indication something wrong with the body and the typical approach to pain is to take appropriate medicine that will help alleviate that pain. However, taking painkillers will have some side effects and it is more complicated, or even life-threatening for those who are allergic to certain painkillers. Imagine a future where pain can be managed or alleviated using a combination...

An illustrated graphic of how the Nerivio Migra device works. Source: Theranica

By Dean Koh 10:40 pm May 28, 2019
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced on May 28 that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra, utilising Remote Electrical Neuromodulation for the acute treatment of migraine. The FDA...
By Dean Koh 04:35 am May 14, 2019
Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced that Omron Ventures has joined its $35M series B funding round, which was announced earlier this March. The investment sum by Omron Ventures has not been disclosed.  Omron Ventures, the venture capital arm of Japan-based Omron Corporation...

An illustrated graphic of how the Nerivio Migra®​ device works. Source: Theranica

By Dean Koh 12:02 am March 19, 2019
Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in...